These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 2416428)

  • 21. The effects on 4-aminoantifolates on 5-formyltetrahydrofolate metabolism in L1210 cells. A biochemical basis of the selectivity of leucovorin rescue.
    Matherly LH; Barlowe CK; Phillips VM; Goldman ID
    J Biol Chem; 1987 Jan; 262(2):710-7. PubMed ID: 2948949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compartmentation of intracellular folates. Failure to interconvert tetrahydrofolate cofactors to dihydrofolate in mitochondria of L1210 leukemia cells treated with trimetrexate.
    Trent DF; Seither RL; Goldman ID
    Biochem Pharmacol; 1991 Aug; 42(5):1015-9. PubMed ID: 1831361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
    Pizzorno G; Chang YM; McGuire JJ; Bertino JR
    Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical pharmacology of the lipophilic antifolate, trimetrexate.
    Jackson RC; Fry DW; Boritzki TJ; Besserer JA; Leopold WR; Sloan BJ; Elslager EF
    Adv Enzyme Regul; 1984; 22():187-206. PubMed ID: 6236675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory control of tetrahydrofolate coenzymes in folate auxotrophs.
    Albrecht AM
    Cancer Treat Rep; 1977 Jul; 61(4):533-8. PubMed ID: 301776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.
    Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID
    Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interconversion of tetrahydrofolate cofactors to dihydrofolate induced by trimetrexate after suppression of thymidylate synthase by fluorodeoxyuridine in L1210 leukemia cells.
    Seither RL; Rape TJ; Goldman ID
    Biochem Pharmacol; 1992 Jun; 43(12):2647-54. PubMed ID: 1385949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
    Seither RL; Rape TJ; Goldman ID
    Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and growth inhibitory effects of the erythro and threo isomers of gamma-fluoromethotrexate, a methotrexate analogue defective in polyglutamylation.
    McGuire JJ; Graber M; Licato N; Vincenz C; Coward JK; Nimec Z; Galivan J
    Cancer Res; 1989 Aug; 49(16):4517-25. PubMed ID: 2472880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictions of a network thermodynamics computer model relating to the mechanism of methotrexate rescue by 5-formyltetrahydrofolate and to the importance of inhibition of thymidylate synthase by methotrexate-polyglutamates.
    White JC
    Adv Exp Med Biol; 1983; 163():305-26. PubMed ID: 6193692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
    Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
    Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR
    Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.
    Shih C; Chen VJ; Gossett LS; Gates SB; MacKellar WC; Habeck LL; Shackelford KA; Mendelsohn LG; Soose DJ; Patel VF; Andis SL; Bewley JR; Rayl EA; Moroson BA; Beardsley GP; Kohler W; Ratnam M; Schultz RM
    Cancer Res; 1997 Mar; 57(6):1116-23. PubMed ID: 9067281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
    Rhee MS; Coward JK; Galivan J
    Mol Pharmacol; 1992 Nov; 42(5):909-16. PubMed ID: 1435754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
    Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
    Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.